BriaCell Therapeutics Corp. (BCTX)

BriaCell Therapeutics Statistics

Total Valuation

BCTX has a market cap or net worth of $13.64 million. The enterprise value is $718,981.

Market Cap	13.64M
Enterprise Value	718,981

Important Dates

The next estimated earnings date is Tuesday, October 28, 2025, after market close.

Earnings Date	Oct 28, 2025
Ex-Dividend Date	n/a

Share Statistics

BCTX has 1.76 million shares outstanding. The number of shares has increased by 119.48% in one year.

Current Share Class	1.76M
Shares Outstanding	1.76M
Shares Change (YoY)	+119.48%
Shares Change (QoQ)	+38.37%
Owned by Insiders (%)	12.62%
Owned by Institutions (%)	4.06%
Float	1.43M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.14
P/TBV Ratio	1.12
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.41

Current Ratio	3.41
Quick Ratio	3.41
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-660.33

Financial Efficiency

Return on equity (ROE) is -688.17% and return on invested capital (ROIC) is -534.73%.

Return on Equity (ROE)	-688.17%
Return on Assets (ROA)	-131.54%
Return on Invested Capital (ROIC)	-534.73%
Return on Capital Employed (ROCE)	-192.71%
Revenue Per Employee	n/a
Profits Per Employee	-$1.21M
Employee Count	16
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -92.74% in the last 52 weeks. The beta is 1.41, so BCTX's price volatility has been higher than the market average.

Beta (5Y)	1.41
52-Week Price Change	-92.74%
50-Day Moving Average	12.14
200-Day Moving Average	45.76
Relative Strength Index (RSI)	42.07
Average Volume (20 Days)	89,225

Short Selling Information

The latest short interest is 351,045, so 20.00% of the outstanding shares have been sold short.

Short Interest	351,045
Short Previous Month	351,132
Short % of Shares Out	20.00%
Short % of Float	24.58%
Short Ratio (days to cover)	0.19

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-24.42M
Pretax Income	-6.04M
Net Income	-19.43M
EBITDA	-24.27M
EBIT	-24.42M
Earnings Per Share (EPS)	-$83.18

Balance Sheet

The company has $12.46 million in cash and n/a in debt, giving a net cash position of $12.46 million or $7.10 per share.

Cash & Cash Equivalents	12.46M
Total Debt	n/a
Net Cash	12.46M
Net Cash Per Share	$7.10
Equity (Book Value)	11.94M
Book Value Per Share	18.93
Working Capital	10.45M

Cash Flow

In the last 12 months, operating cash flow was -$24.07 million and capital expenditures -$456,801, giving a free cash flow of -$24.53 million.

Operating Cash Flow	-24.07M
Capital Expenditures	-456,801
Free Cash Flow	-24.53M
FCF Per Share	-$13.98

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

BCTX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-119.48%
Shareholder Yield	-119.48%
Earnings Yield	-142.48%
FCF Yield	-179.84%

Analyst Forecast

The average price target for BCTX is $40.00, which is 408.26% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$40.00
Price Target Difference	408.26%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-55.67%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on August 25, 2025. It was a reverse split with a ratio of 1:10.

Last Split Date	Aug 25, 2025
Split Type	Reverse
Split Ratio	1:10

Scores

Altman Z-Score	n/a
Piotroski F-Score	1